Series date: 
07/01/2020 - 7:00am CDT to 06/30/2021 - 4:00pm CDT
Location

Please check the individual session for location or broadcast availability.  


Frequency

Weekly


Series Director

Murali Chintagumpala, MBBS


Target Audience and Needs

Faculty, fellows, residents and other healthcare professionals involved in the management of children with central nervous system tumors need to be regularly updated with the recent advances and guidelines in the multidisciplinary management of these tumors. The tumor board aims to increase knowledge of the learners in these topic areas, and encourages learners to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.


Educational Methods

Educational methods will include lectures, case presentations, and literature review.


Objectives

At the conclusion of the sessions, the participants should be able to:

  • Examine the importance of an integrated multi-disciplinary approach to the management of children with brain tumors and incorporate into clinical practice.
  • Explain the rationale for specific tests for the diagnosis and management of pediatric brain tumors.
  • Discuss the design of various phases of clinical trials, and compare the significance of early phase clinical trials versus phase 3 clinical trials.
  • Evaluate the various therapeutic interventions for brain tumors, particularly with reference to neurosurgery, chemotherapy, and radiation therapy.
  • Collect data to assess the process-related problem, devise a plan to improve the process, put it in practice, study the results, and implement the plan if there is improvement.

Evaluation

Participants may be asked to complete a session evaluation.


Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Series Coordinator 

Cynthia Power
csavell@bcm.edu
832-822-4582

Series location: 
Baylor College of Medicine
One Baylor Plaza
Houston, TX 77030
United States

Sessions

Session Date
Management of Sellar Tumors; and Differential Diagnosis and Management of Intracranial Tumors Associated with Hodgkin’s Lymphoma, of Posterior Fossa Tumors, of Supratentorial Tumors, and of Pontine Tumors 09/09/2020 - 7:00am to 8:00am CDT
Differential Diagnosis and Management of Posterior Fossa Tumors, of Spinal Cord Tumors, and of Supratentorial Tumors; and Management of Recurrent Supratentorial Tumors 09/16/2020 - 7:00am to 8:00am CDT
Management of Suspected Recurrent Posterior Fossa Tumors and Recurrent Suprasellar Tumors; Differential Diagnosis and Management of Recurrent Intracranial Tumors; and Management of Recurrent Supratentorial Tumors and of Progressive Supratentorial Tumors 09/23/2020 - 7:00am to 8:00am CDT
Management of Supratentorial Tumors; Differential Diagnosis and Management of Pineal Tumors and Supratentorial Tumors; and Management of Progressive Brainstem Tumors 09/30/2020 - 7:00am to 8:00am CDT
Management of Intracranial Tumors in Patients with NF2; Differential Diagnosis and Management of Posterior Fossa Tumors and Supratentorial Tumors; and Management of Progressive Low-Grade Glioma in Patients with NF1 10/07/2020 - 7:00am to 8:00am CDT
Differential Diagnosis and Management of Pineal Region Tumors; Management of Progressive Chiasmatic, Hypothalamic, or Brainstem Tumors; Management of Recurrent Supratentorial Tumors; and Management of Recurrent Brain Tumors 10/14/2020 - 7:00am to 8:00am CDT
Differential Diagnosis and Management of Suprasellar Tumors, Cervicomedullary Tumors, and Brainstem Tumors 10/21/2020 - 7:00am to 8:00am CDT
Differential Diagnosis and Management of Posterior Fossa Tumors, Optic Pathway Tumors, and Brainstem Tumors 10/28/2020 - 7:00am to 8:00am CDT
Management of Progressive Disseminated Tumors; and Differential Diagnosis and Management of Optic Pathway Tumors, Posterior Fossa Tumors, and Cervicomedullary Tumors 11/04/2020 - 7:00am to 8:00am CST
Management of a Suspected Recurrent Posterior Fossa Tumor; Recurrent Tumor; and Differential Diagnosis and Management of Posterior Fossa Tumors 11/11/2020 - 7:00am to 8:00am CST

Pages